EQ
Price
$0.31
Change
-$0.03 (-8.82%)
Updated
Jun 27 closing price
Capitalization
11.62M
38 days until earnings call
MIST
Price
$1.86
Change
-$0.03 (-1.59%)
Updated
Jun 27 closing price
Capitalization
99.44M
37 days until earnings call
Interact to see
Advertisement

EQ vs MIST

Header iconEQ vs MIST Comparison
Open Charts EQ vs MISTBanner chart's image
Equillium
Price$0.31
Change-$0.03 (-8.82%)
Volume$232.3K
Capitalization11.62M
Milestone Pharmaceuticals
Price$1.86
Change-$0.03 (-1.59%)
Volume$1.09M
Capitalization99.44M
EQ vs MIST Comparison Chart in %
Loading...
EQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MIST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EQ vs. MIST commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EQ is a Buy and MIST is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (EQ: $0.34 vs. MIST: $1.86)
Brand notoriety: EQ and MIST are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EQ: 0% vs. MIST: 112%
Market capitalization -- EQ: $11.07M vs. MIST: $99.44M
EQ [@Biotechnology] is valued at $11.07M. MIST’s [@Biotechnology] market capitalization is $99.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EQ’s FA Score shows that 1 FA rating(s) are green whileMIST’s FA Score has 0 green FA rating(s).

  • EQ’s FA Score: 1 green, 4 red.
  • MIST’s FA Score: 0 green, 5 red.
According to our system of comparison, MIST is a better buy in the long-term than EQ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EQ’s TA Score shows that 5 TA indicator(s) are bullish while MIST’s TA Score has 5 bullish TA indicator(s).

  • EQ’s TA Score: 5 bullish, 2 bearish.
  • MIST’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, EQ is a better buy in the short-term than MIST.

Price Growth

EQ (@Biotechnology) experienced а +4.16% price change this week, while MIST (@Biotechnology) price change was +10.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

EQ is expected to report earnings on Aug 06, 2025.

MIST is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MIST($99.4M) has a higher market cap than EQ($11.6M). MIST YTD gains are higher at: -21.186 vs. EQ (-54.491). EQ has higher annual earnings (EBITDA): -13.65M vs. MIST (-48.18M). MIST has more cash in the bank: 56M vs. EQ (14.5M). EQ has less debt than MIST: EQ (295K) vs MIST (55.6M). EQ has higher revenues than MIST: EQ (30.4M) vs MIST (0).
EQMISTEQ / MIST
Capitalization11.6M99.4M12%
EBITDA-13.65M-48.18M28%
Gain YTD-54.491-21.186257%
P/E RatioN/AN/A-
Revenue30.4M0-
Total Cash14.5M56M26%
Total Debt295K55.6M1%
FUNDAMENTALS RATINGS
EQ vs MIST: Fundamental Ratings
EQ
MIST
OUTLOOK RATING
1..100
4924
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
56
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
9237
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
9550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EQ's Valuation (19) in the Biotechnology industry is somewhat better than the same rating for MIST (56) in the Pharmaceuticals Major industry. This means that EQ’s stock grew somewhat faster than MIST’s over the last 12 months.

EQ's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as MIST (100) in the Pharmaceuticals Major industry. This means that EQ’s stock grew similarly to MIST’s over the last 12 months.

EQ's SMR Rating (98) in the Biotechnology industry is in the same range as MIST (100) in the Pharmaceuticals Major industry. This means that EQ’s stock grew similarly to MIST’s over the last 12 months.

MIST's Price Growth Rating (37) in the Pharmaceuticals Major industry is somewhat better than the same rating for EQ (92) in the Biotechnology industry. This means that MIST’s stock grew somewhat faster than EQ’s over the last 12 months.

MIST's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as EQ (100) in the Biotechnology industry. This means that MIST’s stock grew similarly to EQ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EQMIST
RSI
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
88%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 18 days ago
84%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 10 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
EQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MIST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IMOS18.510.63
+3.54%
ChipMOS TECHNOLOGIES
COO71.141.45
+2.08%
Cooper Companies (The)
LTH30.050.28
+0.94%
Life Time Group Holdings
ELTX7.90N/A
N/A
Elicio Therapeutics
WHLR6.18-0.35
-5.36%
Wheeler Real Estate Investment Trust Inc

EQ and

Correlation & Price change

A.I.dvisor indicates that over the last year, EQ has been loosely correlated with MIST. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if EQ jumps, then MIST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EQ
1D Price
Change %
EQ100%
N/A
MIST - EQ
45%
Loosely correlated
-1.59%
MTNB - EQ
38%
Loosely correlated
-2.32%
IMNM - EQ
31%
Poorly correlated
-0.23%
PRQR - EQ
25%
Poorly correlated
-5.56%
MURA - EQ
25%
Poorly correlated
N/A
More

MIST and

Correlation & Price change

A.I.dvisor indicates that over the last year, MIST has been loosely correlated with EQ. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MIST jumps, then EQ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIST
1D Price
Change %
MIST100%
-1.59%
EQ - MIST
45%
Loosely correlated
N/A
KRYS - MIST
36%
Loosely correlated
-2.60%
ETNB - MIST
32%
Poorly correlated
-0.90%
JBPHF - MIST
31%
Poorly correlated
N/A
GYRE - MIST
29%
Poorly correlated
+0.54%
More